BRIEF-Celgene Inc says Health Canada has expanded indication for REVLIMID in multiple myeloma By: Reuters: Company News January 24, 2017 at 08:11 AM EST * Celgene Inc says Health Canada has expanded indication for REVLIMID in multiple myeloma Read More >> Related Stocks: Celgene Corp